NLRC5 and neoplasm: Pro-tumorigenic chemo/cytokines such as IL-6, IL-10, CCL2, and CCL5 were decreased in NLRC5+ tumor-bearing ascites, correlating with significantly decreased frequency of tolerogenic DC2s subsets in this compartment.